Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
By G. Block, F. Port. American Journal of Kidney Diseases, 2000
624 citations recorded by the source corpus.
Subfields: Nephrology, Surgery
View Paper: https://www.semanticscholar.org/paper/9c4771d24008af802277def4d865c90846e0bfd2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Teng
- M. Wolf
- M. Norma Ofsthun
- J. Lazarus
- C. Camargo
- R. Thadhani
- Miguel A. Hern'an
- Stephen R. Cole
Citations in the corpus
- Activated injectable vitamin D and hemodialysis survival: a historical cohort study. (2005, result): “Nevertheless, previous observational studies implicating alterations of serum calcium, phosphorus, or PTH as independent factors associated with mortality among chronic hemodialysis patients did not often account for whether patients were receiving injectable vitamin D, and whether vitamin D adminis”